<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2018.5988</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-5988</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expression of receptor interacting protein 1 and receptor interacting protein 3 oval cells in a rat model of hepatocarcinogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wójcik</surname><given-names>Marta</given-names></name>
<xref rid="af1-etm-0-0-5988" ref-type="aff">1</xref>
<xref rid="c1-etm-0-0-5988" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Bobowiec</surname><given-names>Ryszard</given-names></name>
<xref rid="af1-etm-0-0-5988" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Lisiecka</surname><given-names>Urszula</given-names></name>
<xref rid="af2-etm-0-0-5988" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Śmiech</surname><given-names>Anna</given-names></name>
<xref rid="af3-etm-0-0-5988" ref-type="aff">3</xref></contrib>
</contrib-group>
<aff id="af1-etm-0-0-5988"><label>1</label>Department of Pathophysiology, Faculty of Veterinary Medicine, University of Life Sciences, 20-033 Lublin, Poland</aff>
<aff id="af2-etm-0-0-5988"><label>2</label>Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences, 20-033 Lublin, Poland</aff>
<aff id="af3-etm-0-0-5988"><label>3</label>Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences, 20-033 Lublin, Poland</aff>
<author-notes>
<corresp id="c1-etm-0-0-5988"><italic>Correspondence to</italic>: Dr Marta W&#x00F3;jcik, Department of Pathophysiology, Faculty of Veterinary Medicine, University of Life Sciences, 12 Akademicka, 20-033 Lublin, Poland, E-mail: <email>marta.wojcik@up.lublin.pl</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>05</month>
<year>2018</year></pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>03</month>
<year>2018</year></pub-date>
<volume>15</volume>
<issue>5</issue>
<fpage>4448</fpage>
<lpage>4456</lpage>
<history>
<date date-type="received"><day>04</day><month>09</month><year>2017</year></date>
<date date-type="accepted"><day>08</day><month>02</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2018, Spandidos Publications</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>When apoptosis is suppressed in a neoplastic state, necroptosis may enable an anticancer response. In the present study, the association between apoptosis and necroptosis was assessed in a partial hepatectomy (PH)/diethylnitrosamine (DEN) rat model of hepatocarcinogenesis. Isolated oval cells (OCs) were analysed at 24, 48 and 72 h and at the first and second week of incubation. Phenotypic studies, apoptosis and necroptosis detection and proliferative activity assays were also performed on the OCs. The OCs were isolated from non-neoplastic (PH) and neoplastic (PH/DEN) livers, which expressed receptor interacting protein (RIP) 1 and RIP3. Western blot analysis revealed that the RIP1 and RIP3 expression in the PH/DEN OCs started to increase at 72 h and continually increased to the end of cell culture. Compared with the PH OCs, the cells isolated from PH/DEN rats exhibited significantly less potential for apoptosis (P&#x003C;0.05). There were a minimal number of apoptotic PH/DEN OCs (2.82&#x00B1;1.1&#x0025;) at 72 h. In addition, the PH/DEN OCs demonstrated progressive proliferative activity during incubation, which was significantly increased compared with the PH OCs at &#x2265;72 h. The present study revealed that PH/DEN OCs, which trigger hepatic cancer, have a high proliferative activity and suppress apoptosis. It was also observed that, based on the expression of RIP3 and RIP1, necroptosis may be maintained and may serve as an alternative pathway for programmed PH/DEN OC death.</p>
</abstract>
<kwd-group>
<kwd>oval cells</kwd>
<kwd>apoptosis</kwd>
<kwd>necroptosis</kwd>
<kwd>hepatocellular carcinoma</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Hepatocellular carcinoma (HCC) is the sixth most common type of cancer with an increasing incidence worldwide (<xref rid="b1-etm-0-0-5988" ref-type="bibr">1</xref>). Despite recent advances in treatment and the understanding of its pathophysiology, HCC remains a disease with a poor prognosis (<xref rid="b1-etm-0-0-5988" ref-type="bibr">1</xref>&#x2013;<xref rid="b2-etm-0-0-5988" ref-type="bibr">2</xref>). HCC typically develops following chronic inflammatory liver disease caused by viral infection, which induces cirrhosis and exposure to chemical carcinogens (<xref rid="b1-etm-0-0-5988" ref-type="bibr">1</xref>) Treatment of advanced HCC disease is largely ineffective, primarily due to therapy-resistance mechanisms (<xref rid="b2-etm-0-0-5988" ref-type="bibr">2</xref>). At present surgical resection and liver transplantation are the best treatment options (<xref rid="b2-etm-0-0-5988" ref-type="bibr">2</xref>). However, a high rate of recurrence and metastasis post curative resection is common and is one of the major causes of mortality in patients with HCC (<xref rid="b1-etm-0-0-5988" ref-type="bibr">1</xref>&#x2013;<xref rid="b2-etm-0-0-5988" ref-type="bibr">2</xref>). Liver oval cells (OCs) possess high proliferative activity, which when disrupted may contribute to HCC (<xref rid="b3-etm-0-0-5988" ref-type="bibr">3</xref>). The number of OCs may be used to evaluate the degree of necroptosis during chemical carcinogenesis as they are rarely isolated form a healthy liver (<xref rid="b3-etm-0-0-5988" ref-type="bibr">3</xref>&#x2013;<xref rid="b5-etm-0-0-5988" ref-type="bibr">5</xref>).</p>
<p>Following OC transformation into cancerous cells, changes in apoptosis and necroptosis serve a key role in hastening the neoplastic state (<xref rid="b6-etm-0-0-5988" ref-type="bibr">6</xref>&#x2013;<xref rid="b8-etm-0-0-5988" ref-type="bibr">8</xref>). To the best of our knowledge, previous studies of experimental hepatocarcinogenesis have only investigated the effect of a failure in one of these programmed cell death pathways (<xref rid="b6-etm-0-0-5988" ref-type="bibr">6</xref>,<xref rid="b9-etm-0-0-5988" ref-type="bibr">9</xref>). A number of previous studies have highlighted the molecular basis of apoptosis resistance in hepatocarcinogenesis, associated with changes to cell death receptors (<xref rid="b6-etm-0-0-5988" ref-type="bibr">6</xref>,<xref rid="b9-etm-0-0-5988" ref-type="bibr">9</xref>,<xref rid="b10-etm-0-0-5988" ref-type="bibr">10</xref>). A novel concept of programmed cell death known as necroptosis has been identified as an alternative form of removing transformed cells when p53-driven apoptosis is disturbed (<xref rid="b7-etm-0-0-5988" ref-type="bibr">7</xref>&#x2013;<xref rid="b11-etm-0-0-5988" ref-type="bibr">11</xref>). In addition, activating necroptosis may serve as a novel therapeutic strategy against neoplastic states for which conventional therapy remains ineffective (<xref rid="b11-etm-0-0-5988" ref-type="bibr">11</xref>).</p>
<p>The primary difference between apoptosis and necroptosis are the molecules which make up the signalling cascades; caspase for apoptosis and RIP1/RIP3 for necroptosis (<xref rid="b12-etm-0-0-5988" ref-type="bibr">12</xref>,<xref rid="b13-etm-0-0-5988" ref-type="bibr">13</xref>). During necroptosis RIP1 and RIP3 form a complex, which triggers the highly regulated process of cell death. The RIP1/RIP3 cytoplasmic necroptotic protein complex is called a necrosome and constitutes a key molecular platform of necroptosis (<xref rid="b7-etm-0-0-5988" ref-type="bibr">7</xref>,<xref rid="b10-etm-0-0-5988" ref-type="bibr">10</xref>,<xref rid="b14-etm-0-0-5988" ref-type="bibr">14</xref>,<xref rid="b15-etm-0-0-5988" ref-type="bibr">15</xref>). A number of factors may trigger nepoptosis, including tumour necrosis factor (TNF), Fas ligand and TNF-related apoptosis inducing ligand (<xref rid="b8-etm-0-0-5988" ref-type="bibr">8</xref>). The overproduction of reactive oxygen species (ROS) damages different macromolecules, including lipids, proteins and DNA and thereby may also contribute to the execution of necroptosis (<xref rid="b8-etm-0-0-5988" ref-type="bibr">8</xref>).</p>
<p>The present study aimed to determine the association between the two different programmed cell death signalling pathways within a rat model of hepatocarcinogenesis, induced by partial hepatectomy (PH) and diethilnitrosamine (DEN) treatment. The present study investigated the hypothesis that necroptosis may have the potential to destroy neoplastic oval cells following the suppression of apoptosis.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Experimental design</title>
<p>A total of 20 female Wistar rats (weight, 200&#x2013;220 g) were used in the present study. The rats were obtained from the Centre of Experimental Medicine, The Medical University of Bialystok (Bialystok, Poland). The rats were housed in pairs in standard polysulfone cages (59&#x00D7;38&#x00D7;20 cm) containing wood-chip bedding material in a temperature (22&#x00B1;1&#x00B0;C) and humidity-controlled (50&#x00B1;10&#x0025;) room with a 12-h light/dark cycle. The animals had <italic>ad libitum</italic> access to standard rat pellet food and tap water. All procedures were approved by the Ethics Committee for Animal Experimentation at the University of Life Sciences (Lublin, Poland; approval number 81/2015).</p>
<p>Following a 1-week period of acclimatisation the 10-week-old rats were divided into two groups for OC induction: i) Non-neoplastic PH, PH was performed and PBS was administered in the drinking water (n=10); and ii) neoplastic PH/DEN, a two-step rat model of hepatocarcinogenesis was performed following the Solt-Farber protocol (n=10) (<xref rid="b16-etm-0-0-5988" ref-type="bibr">16</xref>). A PH (two-thirds) was performed to the rats in each group according to the Higgins and Anderson method via excision of left lateral (~38&#x0025;) and right (~30&#x0025; lobes as previously described (<xref rid="b17-etm-0-0-5988" ref-type="bibr">17</xref>). All surgical procedures were performed under ketamine and xylazine anaesthesia (90 mg/kg and 10 mg/kg, respectively) between 9.00 a.m. and 12.00 p.m. to minimise the diurnal effect of liver regeneration. At 7 days following PH, DEN (50 mg/l; Sigma Aldrich; Merck KGaA, Darmstadt, Germany) was added to the drinking water of the neoplastic group of rats and supplied <italic>ad libitum</italic> for a period of 10 weeks. The non-neoplastic group were administered PBS. Following this 10-week period, an exploratory laparotomy was performed in the PH/DEN rats and the development of tumours on the liver surface was confirmed.</p>
</sec>
<sec>
<title>In vivo and in vitro experimental design</title>
<p>After 10 weeks OCs were isolated from each group as described previously (<xref rid="b4-etm-0-0-5988" ref-type="bibr">4</xref>). OC cells were isolated during the exploratory laparotomy in the PH/DEN group and during a regular laparotomy in the PH group. Prior to the laparotomy, rats were anesthetised with intramuscular administration of ketamine (90 mg/kg) and xylazine (10 mg/kg). The liver was perfused <italic>in situ</italic> through the portal vein with a Krebs-Ringer buffer (Sigma Aldrich; Merck KGaA) made up of three parts as follows: i) Containing EGTA, ii) without Ca<sup>2&#x002B;</sup> and chelating agent and iii) with type IV collagenase. Following perfusion, the liver was transferred to Ham&#x0027;s F-12/Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM; 1:1 v/v; Sigma Aldrich; Merck KGaA), minced, filtered through a double gauze and digested for 1 h at 37&#x00B0;C in PBS containing 0.1&#x0025; collagenase, 0.25&#x0025; trypsin, 0.004&#x0025; DNase I and 0.1&#x0025; pronase E (all Sigma Aldrich; Merck KGaA), which selectively digested mature hepatocytes into undetectable debris. The mixture was subsequently decanted through a 70 &#x00B5;m-nylon mesh followed by a 40 &#x00B5;m-nylon mesh and then loaded on a discontinuous gradient of Percoll and centrifuged at 420 &#x00D7; g for 20 min at 4&#x00B0;C. Density gradient centrifugation is an effective method of separating OCs from the remaining liver cell fractions (<xref rid="b12-etm-0-0-5988" ref-type="bibr">12</xref>). In comparison with the other methods, including flow cytometry and immunomagnetic sorting, density gradient centrifugation in Percoll, followed by specific enzymatic digestion leads to the isolation of pure OCs with a high viability (<xref rid="b18-etm-0-0-5988" ref-type="bibr">18</xref>&#x2013;<xref rid="b19-etm-0-0-5988" ref-type="bibr">19</xref>).</p>
<p>The collected cell suspension was washed with antibiotic supplemented (100 U/ml penicillin, 0.1 mg/ml streptomycin, 10 mg/ml gentamycin) Ham&#x0027;s F-12/DMEM medium containing 10&#x0025; fetal calf serum (Sigma Aldrich; Merck KGaA) and plated at 250,000 cells/well in 1,000 &#x00B5;l Ham&#x0027;s F-12/DMEM (1:1 v/v) medium in a 24-well plate at 37&#x00B0;C with 5&#x0025; CO<sub>2</sub>. The viability of the cells was estimated using the Trypan-blue exclusion method and was between 75&#x2013;85&#x0025;. A total of 180 &#x00B5;l Trypan blue (Sigma Aldrich; Merck KGaA) was mixed with 20 &#x00B5;l cell suspension and 50 &#x00B5;l of the mixture was dropped on a B&#x00FC;rker counting chamber. The number of viable cells (with a clear cytoplasm) and dead cells (with a blue cytoplasm) was determined in 24 squares (0.25 mm<sup>2</sup>) of the B&#x00FC;rker chamber as previously described (<xref rid="b20-etm-0-0-5988" ref-type="bibr">20</xref>). Adhered OCs from the PH and PH/DEN groups were cultured in HAMS-12/DMEM (v/v) medium at 37&#x00B0;C with 5&#x0025; CO<sub>2</sub>. The medium and cells were analysed at 24, 48 and 72 h, and the first and second week of incubation.</p>
</sec>
<sec>
<title>Biochemical analysis</title>
<p>Serum levels of alanine aminotransferase (ALT; cat. no. A11A01627), aspartate aminotransferase (AST; cat. no. A11A01629), &#x03B3;-glutamyl transferase (GGT; cat. no. A11A01630) and alkaline phosphatase (AP; cat. no. A11A01626) were quantified using a kinetic methods with an ABX Pentra 400 (HORIBA Ltd., Kyoto, Japan) using commercially available tests from HORIBA Ltd. All procedures were performed according manufacture&#x0027;s protocol.</p>
</sec>
<sec>
<title>Histopathological examination of the liver tissue</title>
<p>Liver tissues were fixed for 24 h at room temperature in 10&#x0025; phosphate-buffered formalin, embedded in paraffin and sectioned at 3&#x2013;5 &#x00B5;m using a rotary microtome (Leica SR-200; Leica Microsystems, Ltd., Milton Keynes, UK) prior to histological examination. The sections were stained at room temperature with haematoxylin (5 min) and eosin (5 min) for histological observation. The histological analyses were performed via light microscopy (Eclipse E-600; Nikon Corporation, Tokyo, Japan) at magnification, &#x00D7;200. The hepatic injures were assessed according to the World Health Organisation Histological Classification of Tumours (<xref rid="b21-etm-0-0-5988" ref-type="bibr">21</xref>).</p>
</sec>
<sec>
<title>Morphological characterisation of isolated OCs</title>
<p>The OCs were cultured at 36&#x00B0;C for 2 weeks in Ham&#x0027;s F-12/DMEM mixture (1:1 v/v). On each day of culture the OCs were subjected to microscopic analysis of the morphology under a phase-contrast microscope (Olympus CK40; Olympus Corporation, Tokyo, Japan). The appearance of the cells, colony formation, spread of cell culture and the construction or lack of a monolayer was analysed.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>At various time points (24, 48, 72 h and 1st and 2nd week) the OCs were harvested in a lysis buffer composed of 0.2&#x0025; Nonidet-P40, 150 mmol/l NaCl, 20 mmol/l Tris, 2 mmol EDTA, 0.1&#x0025; glycerol, 10 mmol/l dithiothreitol and a cOmplete<sup>&#x2122;</sup> protease inhibitor cocktail (Roche; Sigma-Aldrich; Merck KGaA). Concentration of obtained protein was analysed by Lowry method (<xref rid="b22-etm-0-0-5988" ref-type="bibr">22</xref>). Equal amounts (30 &#x00B5;g/lane) of protein were separated by 12&#x0025; SDS-PAGE, transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and blocked for 1 h at 20&#x00B0;C with PBS containing 5&#x0025; low-fat milk. Following washing with Tris-buffered saline and 0.1&#x0025; Tween-20 (Sigma Aldrich; Merck KGaA), the membranes were incubated overnight at 4&#x00B0;C with primary antibodies directed against cytokeratine-19 (CK19; 1:200; cat. no. M0888), albumin (Alb; 1:1,000; cat. no. F0117; both Dako; Agilent Technologies, Inc., Santa Clara, CA, USA), &#x03B1;-fetoprotein (Afp; cat. no. ab46799), RIPK1 (cat. no. ab106393) and RIPK3 (cat. no. ab56164) (all 1:200; Abcam, Cambridge, UK). The washed membranes were subsequently incubated for 3 h at 4&#x00B0;C with alkaline phosphatase-labelled goat anti-mouse (cat. no. P0447) or anti-rabbit (cat. no. P0448) (both 1:15,000; Dako; Agilent Technologies, Inc.) secondary antibodies. The protein bands were visualised using colorimetric detection (GelDog XR system; Bio-Rad Laboratories, Inc.) and analysed using Quantity One 1-D analysis software version 4.6.3 (Bio-Rad Laboratories, Inc.) (<xref rid="b4-etm-0-0-5988" ref-type="bibr">4</xref>).</p>
</sec>
<sec>
<title>Apoptosis detection using flow cytometry (FCM)</title>
<p>Apoptosis detection was performed using an Annexin V/FITC assay kit (Bio-Rad Laboratories, Inc.) according to the manufacture&#x0027;s protocol. The OCs were washed in PBS and centrifuged at 420 &#x00D7; g for 10 min at 4&#x00B0;C and the supernatant was discarded. The cell pellet was suspended in the binding buffer and adjusted to a concentration of 5&#x00D7;10<sup>5</sup> cells/ml. A total of 5 &#x00B5;l Annexin V-fluorescein isothiocyanate (FITC) solution was added and the cells were incubated for 15 min at room temperature in the dark. A total of 10 &#x00B5;l propidium iodide (PI) was subsequently added and the probes were incubated for 15 min in the dark at room temperature. The suspension was subsequently centrifuged at 300 &#x00D7; g for 5 min at room temperature, re-suspended in 200 &#x00B5;l binding buffer and analysed using System XL-II software with a Coulter Epics XL flow cytometer (Beckman Coulter, Inc., Brea, CA, USA) (<xref rid="b23-etm-0-0-5988" ref-type="bibr">23</xref>).</p>
</sec>
<sec>
<title>Cell proliferation assay</title>
<p>To detect the proliferation rate of PH and PH/DEN OCs, an ELISA-Bromodeoxyuridine (BrdU) kit (Abcam; cat. no. ab126556) was used according to the manufacturer&#x0027;s protocol. This test measures the BrdU incorporated into newly synthesised cellular DNA. The cells were seeded in a 96-well plate at a density of 2&#x00D7;10<sup>5</sup> cells/well in 100 &#x00B5;l Ham&#x0027;s F-12/DMEM (1:1 v/v) culture medium. A total of 20 &#x00B5;l diluted 1:500 BrdU was added to the OCs in the plates and incubated at 37&#x00B0;C for 4 h (BrdU incorporation). Following removal of the culture medium the cells were fixed for 30 min at room temperature with FixDenat (provided with the test kit) followed by incubation with peroxide-conjugated monoclonal antibodies to the thymidine-analogue 5-bromo-2deoxyuridine Fab fragments, which bind with the incorporated DNA. Following the addition of substrate solution, the immune complexes were detected at 450 nm using an ELx800<sup>&#x2122;</sup> ELISA reader (BioTek Instruments, Inc., Winooski, VT, USA).</p>
</sec>
<sec>
<title>Superoxide anion assay</title>
<p>Superoxide anion production was measured as previously described (<xref rid="b23-etm-0-0-5988" ref-type="bibr">23</xref>). OCs were incubated with 0.1&#x0025; nitroblue tetrazolium (Sigma-Aldrich; Merck KGaA) solution at room temperature for 10 min and the absorbance was read at 545 nm. Nanomoles of superoxide produced over the incubation period were calculated using the extinction coefficient of 21.1 nmol (<xref rid="b24-etm-0-0-5988" ref-type="bibr">24</xref>).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All experiments were repeated a minimum of three times with different batches of cell samples. Data are presented as the mean &#x00B1; standard deviation. Data were analysed using one-way analysis of variance (ANOVA) or Student&#x0027;s t-test as appropriate. When ANOVA indicated significant differences within groups, comparisons were made using Tukey&#x0027;s post hoc test. P&#x003C;0.05 was considered to indicate a statistically significant difference. Statistical analyses were performed using STATISTICA version 13.1 software (StatSoft Ltd., Bedford, UK).</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Body weight and blood biochemical analyses</title>
<p>Rats in the PH/DEN group had a slower growth rate compared with the PH group. At the time of sacrifice the average body weight was significantly (~20&#x0025;) lower in the PH/DEN group compared with the PH group (<xref rid="tI-etm-0-0-5988" ref-type="table">Table I</xref>). Blood analyses indicated that AST, ALT, AP and GGT levels were significantly higher in the PH/DEN group compared with the PH group (<xref rid="tI-etm-0-0-5988" ref-type="table">Table I</xref>).</p>
</sec>
<sec>
<title>Histological examination</title>
<p>The livers of the PH (<xref rid="f1-etm-0-0-5988" ref-type="fig">Fig. 1A</xref>) and PH/DEN (<xref rid="f1-etm-0-0-5988" ref-type="fig">Fig. 1B</xref>) rats were examined. Normal liver histology was observed in the PH group (<xref rid="f1-etm-0-0-5988" ref-type="fig">Fig. 1C</xref>). The liver histology of animals in the PH/DEN group was characterised by chronic damage and areas of cellular atypia (black arrow; <xref rid="f1-etm-0-0-5988" ref-type="fig">Fig. 1D</xref>). The signs included lymphocytic infiltration, cells with enlarged nuclei and atypical hepatocytes.</p>
</sec>
<sec>
<title>Phenotype of primary PH and PH/DEN OCs</title>
<p>Western blot analysis was performed to detect the stem cell markers Afp, CK19 and Alb to determine whether rat OCs were activated in each group (<xref rid="f2-etm-0-0-5988" ref-type="fig">Fig. 2A</xref>). Each group was positive for Afp and CK19, the classical OC markers immediately following isolation. The isolated OCs also co-expressed Alb at a high level. One way of defining a cell population as a progenitor OC is to clarify its ability to multiply and differentiate into hepatocytes and cholangiocytes. The freshly isolated cells expressed hepatocytic (Alb) and cholangiocytic markers (CK19), indicating that they were bipotential hepatic stem cells. Afp and CK19 were not detected in PH OCs following 2 weeks of incubation (whereas Alb was detected at all time points of the experiment), which indicates that PH OCs successively gave rise to novel hepatocytes. By contrast, the expression of Alb by PH/DEN OCs gradually disappeared throughout incubation.</p>
<p>Freshly isolated OCs were round in shape and had a high nuclear to cytoplasmic ratio. PH OCs attached to the culture dish within 24 h and grew to confluence within 72 h as spindle-shaped cells (<xref rid="f2-etm-0-0-5988" ref-type="fig">Fig. 2B</xref>). From the first week of incubation, the PH cells composed a flat monolayer and began to differentiate into cells of mature morphology, which was clearly visible in the second week of incubation (<xref rid="f2-etm-0-0-5988" ref-type="fig">Fig. 2B</xref>). This maturation of cells was additionally confirmed by a strong Alb expression (<xref rid="f2-etm-0-0-5988" ref-type="fig">Fig. 2A</xref>).</p>
<p>The PH/DEN group OCs expanded in the culture without creating a regular monolayer. It was observed that some of the cells were round mononuclear cells with an oval-like appearance, however some were longitudinal. Following 1 week of culture, the PH/DEN OCs aggregated and formed colonies. At 2 weeks incubation there was intensive multiplying of the OCs.</p>
</sec>
<sec>
<title>RIP1 and RIP3 protein expression alters under non-neoplastic and neoplastic conditions</title>
<p>OCs isolated from PH and PH/DEN livers expressed RIP1 and RIP3 protein throughout culture (<xref rid="f3-etm-0-0-5988" ref-type="fig">Fig. 3</xref>). The expression of RIP1 and RIP3 proteins by OCs remained constant in the PH group, however, a notable increase in RIP1 and RIP3 protein expression was observed in the PH/DEN group following 72 h incubation (<xref rid="tII-etm-0-0-5988" ref-type="table">Table II</xref>). In addition, the bands density of RIP1 and RIP3 obtained in the 1st and 2nd week of PH/DEN OCs incubation, were significantly higher (P&#x003C;0.05) compared with the PH group at the same time points (<xref rid="tII-etm-0-0-5988" ref-type="table">Table II</xref>). At the 2nd week the PH/DEN OCs exhibited the strongest staining of RIP1 and RIP3 at 3.488,89 and 3.547,67 INT/mm<sup>2</sup>, respectively (<xref rid="tII-etm-0-0-5988" ref-type="table">Table II</xref>). It appears that, conversely to non-neoplastic OCs, the time of incubation intensifies RIP1- and RIP3-dependent necroptotic death in neoplastic cells.</p>
</sec>
<sec>
<title>FITC-Annexin V/PI bivariate FCM</title>
<p>During the initial 48 h of OC incubation in the PH group, the mean number of apoptotic cells was 10.56&#x00B1;0.5&#x0025; (<xref rid="f4-etm-0-0-5988" ref-type="fig">Fig. 4</xref>). At 72 h the percentage of apoptotic cells significantly increased to 33.58&#x00B1;0.5&#x0025;, which was markedly decreased at 2 weeks (30.08&#x00B1;0.83&#x0025;). Compared with the PH OCs, the cells isolated from the PH/DEC group exhibited significantly less apoptosis between 72 h and 2 weeks. There were particularly few apoptotic cells (2.82&#x00B1;1.1&#x0025;) in the PH/DEN group at 72 h. The level of apoptosis in the PH/DEN group gradually increased and was significantly increased at 2 weeks compared with 1 week, however at no time point did it exceed 15.94&#x00B1;0.9&#x0025; of all cultured cells. Concurrent staining with Annexin V and PI revealed differences between the percentage of apoptotic PH and PH/DEN OCs. Whereas in PH-OCs apoptosis intensified concomitantly with the time of incubation, (bottom and upper right quadrants) live neoplastic OCs dominated independently of the time of cell culture (bottom left quadrant).</p>
</sec>
<sec>
<title>Proliferation activity of isolated PH and PH/DEN OCs</title>
<p>The proliferative activity of PH OCs gradually increased from 24 h (0.47&#x00B1;0.03) to the first week of incubation (1.1&#x00B1;0.3), however at the second week there was a slight reduction (0.98&#x00B1;0.1; <xref rid="f5-etm-0-0-5988" ref-type="fig">Fig. 5</xref>). In contrast, PH/DEN OCs demonstrated increased proliferative activity at each time point, reaching the highest value at the second week (1.99&#x00B1;0.09). The proliferative activity of PH/DEN OCs was significantly increased compared with the PH OCs at the same time point between 72 h and the second week.</p>
</sec>
<sec>
<title>ROS generation by PH and PH/DEN OCs</title>
<p>ROS production by PH OCs increased gradually from 0.70&#x00B1;0.03 to 2.50&#x00B1;0.37 nM/25&#x00D7;10<sup>4</sup> cells from 24 h to the first week of incubation (<xref rid="tIII-etm-0-0-5988" ref-type="table">Table III</xref>). PH/DEN OCs generated significantly increased amounts of ROS at each time point compared with the PH group, The highest ROS production occurred in the first week of cell incubation in each group and reached 2.50&#x00B1;0.37 nM/2.5&#x00D7;10<sup>4</sup> cells in the PH group and 3.70&#x00B1;0.27 nM/2.5&#x00D7;10<sup>4</sup> cells in the PH/DEN group. Despite the slight decrease in ROS production (3.2&#x00B1;0.37 nM/2.5&#x00D7;10<sup>4</sup> cells) at the 2nd week in the PH/DEN group, this value was still significantly increased compared with the PH group.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>During the culture of PH OCs, RIP1 expression fluctuated between 10.92 and 12.49&#x0025;, while RIP3 expression steadily decreased from 14.57&#x2013;9.20&#x0025;. At 48 h RIP1 and RIP3 expression was notably lower in the PH/DEN group, however it steadily increased over time and was significantly higher at 2 weeks compared with the PH group. In addition, it was connected with a high percentage of apoptotic cells, particularly after 48 h of PH OCs culture; it appears that apoptosis dominates in isolated PC OCs. Conversely it was observed that RIP1 and RIP3 expression increased concomitantly with apoptosis suppression in OCs obtained from the PH/DEN group. However, at all time points these cells exhibited a stronger RIP3 expression compared with RIP1. These slight but visible differences in RIP1 and RIP3 expression in PH/DEN OCs indicated that RIP1 may be dispensable for necroptosis induction and that RIP3 serves a pivotal role during necroptosis induction. According to Kearney <italic>et al</italic> (<xref rid="b25-etm-0-0-5988" ref-type="bibr">25</xref>) RIP1 knockdown accelerated necroptosis induced by different stimuli and acts as an inhibitor of the process rather than a stimulator. In addition, Upton <italic>et al</italic> (<xref rid="b26-etm-0-0-5988" ref-type="bibr">26</xref>) reported that necroptosis induced by murine cytomegaloviruses went preferentially via the RIP3-dependent pathway as opposed to the RIP1-dependent pathway. A number of previous studies have demonstrated that RIP1 and RIP3 are essential mediators of necroptosis, which interact via their RIP homotypic interaction motif domains (<xref rid="b13-etm-0-0-5988" ref-type="bibr">13</xref>,<xref rid="b27-etm-0-0-5988" ref-type="bibr">27</xref>&#x2013;<xref rid="b30-etm-0-0-5988" ref-type="bibr">30</xref>). In this case execution of RIP1/RIP3 interaction involves an active disintegration of mitochondrial, lysomal and plasma membranes (<xref rid="b13-etm-0-0-5988" ref-type="bibr">13</xref>).</p>
<p>Previous studies have revealed that apoptotic defects are the most frequent cause of cancer cell immortality and drug resistance, which limits the efficacy of cancer chemotherapy (<xref rid="b10-etm-0-0-5988" ref-type="bibr">10</xref>,<xref rid="b14-etm-0-0-5988" ref-type="bibr">14</xref>). In the present study, the percentage of apoptotic PH/DEN OCs was lower than the percentage of apoptotic PH OCs at every time point. There was a significant apoptosis enhancement in the PH/DEN OCs at 2 weeks compared with 72 h and strong RIP1 expression was observed. These results suggest that as well as its association with necroptosis, RIP1 may be associated with the regulation of apoptosis (<xref rid="b12-etm-0-0-5988" ref-type="bibr">12</xref>,<xref rid="b29-etm-0-0-5988" ref-type="bibr">29</xref>). In response to death receptor activation, a mitochondrial apoptogenic factor, such as Smac protein, induces the auto-degradation of cellular inhibitor of apoptosis protein (cIAP) 1 and cIAP2, which accelerates the formation of the RIP1-containing caspase-8 activating complex (<xref rid="b12-etm-0-0-5988" ref-type="bibr">12</xref>,<xref rid="b28-etm-0-0-5988" ref-type="bibr">28</xref>). Prolonged incubation of PH/DEN OCs intensifies caspase-dependent cell death but not at the same level as that obtained in PH OCs. Schattenberg <italic>et al</italic> (<xref rid="b9-etm-0-0-5988" ref-type="bibr">9</xref>) previously reported that the failure of transformed neoplastic cells to undergo apoptosis severely disrupts tissue homeostasis and allows proliferation of the resistant clone, which is a phenomenon frequently observed in HCC. Similarly, the PH/DEN OCs cultured in the present study exhibited significantly increased proliferation activity compared with the PH OCs, particularly in the final week of incubation. Declercq <italic>et al</italic> (<xref rid="b28-etm-0-0-5988" ref-type="bibr">28</xref>) previously reported that when apoptotic cell death is reduced or blocked by caspase inhibitors, cells may use necroptosis as an alternative cell death pathway. The results of the present study support this suggestion. A number of previous studies have demonstrated that limited cancer necroptosis may contribute to tumour formation and resistance to cancer therapies (<xref rid="b7-etm-0-0-5988" ref-type="bibr">7</xref>,<xref rid="b14-etm-0-0-5988" ref-type="bibr">14</xref>,<xref rid="b15-etm-0-0-5988" ref-type="bibr">15</xref>,<xref rid="b30-etm-0-0-5988" ref-type="bibr">30</xref>). In addition, it has been previously reported that the inhibition of caspase activity, one of the hallmarks of apoptosis, enhances necroptosis (<xref rid="b7-etm-0-0-5988" ref-type="bibr">7</xref>,<xref rid="b14-etm-0-0-5988" ref-type="bibr">14</xref>). The results of the present study revealed that a low level of apoptosis PH/DEN OCs was associated with higher RIP3 expression. The authors suggest that although this response enhances necroptotic cell death, it is not enough to break the highly proliferative activity of neoplastic OCs. The results indicated an increased level of superoxide released by PH/DEN OCs, which may participate in the regulation of necroptotic response. The ROS may act as a stimuli of necroptosis (<xref rid="b27-etm-0-0-5988" ref-type="bibr">27</xref>). Christofferson and Yuan (<xref rid="b27-etm-0-0-5988" ref-type="bibr">27</xref>) demonstrated that ROS acts as an effector of necroptosis in a cell-type-dependent manner, which was reflected by the intensified proliferation of PH/DEN OCs under experimental conditions in the present study.</p>
<p>The results of the present study indicated that although PH/DEN OCs demonstrated high proliferative activity with apoptosis suppression, their necroptosis potential was preserved. This was reflected by the pronounced expression of RIP3 and unchanged expression of RIP1. Optimal necroptosis may serve as an effective treatment for hepatocarcinogenesis and these findings clarify the importance of this alternative pathway of programmed cell death.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>The present study was supported by a grant from the National Science Centre in Poland (grant no. DEC-2014/15/B/Nz5/01587).</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>All data generated or analysed during this study are included in this published article.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>MW isolated and cultured the OCs, performed western blot analysis, analysed cell proliferation and ROS generation and prepared the manuscript. RB performed statistical analysis and revised the manuscript prior to submission. UL determined apoptosis in OCs by flow cytometry. A&#x015A; performed histopathological examination of the liver slides.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The present study was approved by the Ethics Committee for Animal Experimentation at The University of Life Sciences (Lublin, Poland; approval number 81/2015).</p>
</sec>
<sec>
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors confirm that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-5988"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlageter</surname><given-names>M</given-names></name><name><surname>Terracciano</surname><given-names>LM</given-names></name><name><surname>D&#x0027;Angelo</surname><given-names>S</given-names></name><name><surname>Sorrentino</surname><given-names>P</given-names></name></person-group><article-title>Histopatholgy of hepatocellular carcinoma</article-title><source>World J Gastroenterol</source><volume>20</volume><fpage>15955</fpage><lpage>15964</lpage><year>2014</year><pub-id pub-id-type="doi">10.3748/wjg.v20.i43.15955</pub-id><pub-id pub-id-type="pmid">25473149</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-5988"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Ke</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Heme-oxygenase-1: A molecular brake on hepatocellular carcinoma cell migration</article-title><source>Carcinogenesis</source><volume>32</volume><fpage>1840</fpage><lpage>1848</lpage><year>2011</year><pub-id pub-id-type="doi">10.1093/carcin/bgr225</pub-id><pub-id pub-id-type="pmid">22016469</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-5988"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KP</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Park</surname><given-names>HD</given-names></name><name><surname>Byun</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>MC</given-names></name><name><surname>Jeong</surname><given-names>WI</given-names></name><name><surname>Calvisi</surname><given-names>DF</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Lim</surname><given-names>DS</given-names></name></person-group><article-title>The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis</article-title><source>Proc Natl Acad Sci USA</source><volume>107</volume><fpage>8248</fpage><lpage>8253</lpage><year>2010</year><pub-id pub-id-type="doi">10.1073/pnas.0912203107</pub-id><pub-id pub-id-type="pmid">20404163</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-5988"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F3;jcik</surname><given-names>M</given-names></name><name><surname>Bobowiec</surname><given-names>R</given-names></name><name><surname>Martelli</surname><given-names>F</given-names></name></person-group><article-title>Effect of carotenoids on in vitro proliferation and differentiation of oval cells during neoplastic and non-neoplastic liver injures in rats</article-title><source>J Physiol Pharmacol</source><volume>59</volume><supplement>Suppl 2</supplement><fpage>S203</fpage><lpage>S213</lpage><year>2008</year></element-citation></ref>
<ref id="b5-etm-0-0-5988"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>Hippo signalling in oval cells and hepatocarcinogenesis</article-title><source>Cancer Lett</source><volume>302</volume><fpage>91</fpage><lpage>99</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.canlet.2010.12.008</pub-id><pub-id pub-id-type="pmid">21247686</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-5988"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>C</given-names></name><name><surname>Ruan</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name></person-group><article-title>Signaling network of OSW-1-induced apoptosis and necroptosis in hepatocellular carcinoma</article-title><source>Mol Med Rep</source><volume>7</volume><fpage>1646</fpage><lpage>1650</lpage><year>2013</year><pub-id pub-id-type="doi">10.3892/mmr.2013.1366</pub-id><pub-id pub-id-type="pmid">23503804</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-5988"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulda</surname><given-names>S</given-names></name></person-group><article-title>The mechanism of necroptosis in normal and cancer cell</article-title><source>Cancer Biol Ther</source><volume>14</volume><fpage>999</fpage><lpage>1004</lpage><year>2013</year><pub-id pub-id-type="doi">10.4161/cbt.26428</pub-id><pub-id pub-id-type="pmid">24025353</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-5988"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jouan-Lanhouet</surname><given-names>S</given-names></name><name><surname>Riquet</surname><given-names>F</given-names></name><name><surname>Duprez</surname><given-names>L</given-names></name><name><surname>Vanden Berhe</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Vandenabeele</surname><given-names>P</given-names></name></person-group><article-title>Necroptosis, in vivo detection in experimental disease models</article-title><source>Semin Cell Devel Biol</source><volume>35</volume><fpage>2</fpage><lpage>13</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.08.010</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-5988"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schattenberg</surname><given-names>JM</given-names></name><name><surname>Schumann</surname><given-names>M</given-names></name><name><surname>Galle</surname><given-names>PR</given-names></name></person-group><article-title>Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways</article-title><source>J Gastroenterol Hepatol</source><volume>26</volume><supplement>Suppl 1</supplement><fpage>S213</fpage><lpage>S219</lpage><year>2011</year><pub-id pub-id-type="doi">10.1111/j.1440-1746.2010.06582.x</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-5988"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><article-title>Targeting the weak point of cancer by induction of necroptosis</article-title><source>Autophagy</source><volume>3</volume><fpage>490</fpage><lpage>492</lpage><year>2007</year><pub-id pub-id-type="doi">10.4161/auto.4592</pub-id><pub-id pub-id-type="pmid">17617736</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-5988"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Kon</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Su</surname><given-names>T</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Baer</surname><given-names>R</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name></person-group><article-title>Ferroptosis as a p53-mediated activity during tumor suppression</article-title><source>Nature</source><volume>520</volume><fpage>57</fpage><lpage>62</lpage><year>2015</year><pub-id pub-id-type="doi">10.1038/nature14344</pub-id><pub-id pub-id-type="pmid">25799988</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-5988"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Miao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha</article-title><source>Cell</source><volume>137</volume><fpage>1100</fpage><lpage>1111</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.cell.2009.05.021</pub-id><pub-id pub-id-type="pmid">19524512</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-5988"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandenabeele</surname><given-names>P</given-names></name><name><surname>Galluzi</surname><given-names>L</given-names></name><name><surname>Vanden Berghe</surname><given-names>T</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Molecular mechanisms of necroptosis: An ordered cellular explosion</article-title><source>Nat Rev Mol Cell Biol</source><volume>11</volume><fpage>700</fpage><lpage>714</lpage><year>2010</year><pub-id pub-id-type="doi">10.1038/nrm2970</pub-id><pub-id pub-id-type="pmid">20823910</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-5988"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulda</surname><given-names>S</given-names></name></person-group><article-title>Therapeutic exploitation of necroptosis for cancer therapy</article-title><source>Semin Cell Dev Biol</source><volume>35</volume><fpage>51</fpage><lpage>56</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.07.002</pub-id><pub-id pub-id-type="pmid">25065969</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-5988"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>WK</given-names></name><name><surname>Jun</surname><given-names>DW</given-names></name></person-group><article-title>Necroptosis: An emerging type of cell death in liver diseases</article-title><source>World J Gastroenterol</source><volume>20</volume><fpage>12526</fpage><lpage>12532</lpage><year>2014</year><pub-id pub-id-type="doi">10.3748/wjg.v20.i35.12526</pub-id><pub-id pub-id-type="pmid">25253954</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-5988"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solt</surname><given-names>D</given-names></name><name><surname>Farber</surname><given-names>E</given-names></name></person-group><article-title>New principle for the analysis of chemical carcinogenesis</article-title><source>Narure</source><volume>263</volume><fpage>701</fpage><lpage>703</lpage><year>1976</year></element-citation></ref>
<ref id="b17-etm-0-0-5988"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>G</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name></person-group><article-title>Experimental pathology of the liver restoration of the liver of the white rat following partial surgical removal</article-title><source>Arch Pathol (Chic)</source><volume>12</volume><fpage>186</fpage><lpage>202</lpage><year>1931</year></element-citation></ref>
<ref id="b18-etm-0-0-5988"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shupe</surname><given-names>TD</given-names></name><name><surname>Piscaglia</surname><given-names>AC</given-names></name><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Gasbarrini</surname><given-names>A</given-names></name><name><surname>Petersen</surname><given-names>BE</given-names></name></person-group><article-title>Isolation and characterization of hepatic stem cells, or &#x2018;oval cells,&#x2019; from rat livers</article-title><source>Method Mol Biol</source><volume>482</volume><fpage>387</fpage><lpage>405</lpage><year>2009</year><pub-id pub-id-type="doi">10.1007/978-1-59745-060-7_24</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-5988"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>ZP</given-names></name><name><surname>Tan</surname><given-names>WQ</given-names></name><name><surname>Tang</surname><given-names>YF</given-names></name><name><surname>Zhang</surname><given-names>HJ</given-names></name><name><surname>Feng</surname><given-names>MF</given-names></name></person-group><article-title>Activation, isolation, identification and in vitro proliferation of oval cells from adult rat livers</article-title><source>Cell Prolif</source><volume>37</volume><fpage>177</fpage><lpage>187</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.1365-2184.2004.00293.x</pub-id><pub-id pub-id-type="pmid">15030551</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-5988"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strober</surname><given-names>W</given-names></name></person-group><article-title>Trypan blue exclusion test of cell viability</article-title><source>Curr Protoc Immunol</source><volume>21</volume><fpage>3B:A.3B.1</fpage><lpage>A.3B.2</lpage><year>2001</year></element-citation></ref>
<ref id="b21-etm-0-0-5988"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Head</surname><given-names>KW</given-names></name><name><surname>Cullen</surname><given-names>JM</given-names></name><name><surname>Dubielzig</surname><given-names>RR</given-names></name><name><surname>Else</surname><given-names>RW</given-names></name><name><surname>Misdorp</surname><given-names>W</given-names></name><name><surname>Patnaik</surname><given-names>AK</given-names></name><name><surname>Tateyama</surname><given-names>S</given-names></name><name><surname>Van Der Gaag</surname><given-names>I</given-names></name></person-group><chapter-title>Histological Classification of Tumors of the Alimentary System of Domestic Animals</chapter-title><source>Second Series</source><publisher-name>WHO, Armed Forces Institute of Pathology</publisher-name><publisher-loc>Washington, DC</publisher-loc><year>2003</year></element-citation></ref>
<ref id="b22-etm-0-0-5988"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>OH</given-names></name><name><surname>Rosebrough</surname><given-names>NJ</given-names></name><name><surname>Farr</surname><given-names>AL</given-names></name><name><surname>Randall</surname><given-names>RJ</given-names></name></person-group><article-title>Protein measurement with the Folin phenol reagent</article-title><source>J Biol Chem</source><volume>193</volume><fpage>265</fpage><lpage>275</lpage><year>1951</year><pub-id pub-id-type="pmid">14907713</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-5988"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F3;jcik</surname><given-names>M</given-names></name><name><surname>Bobowiec</surname><given-names>R</given-names></name><name><surname>Lisiecka</surname><given-names>U</given-names></name><name><surname>Kostro</surname><given-names>K</given-names></name></person-group><article-title>Proliferation, differentiation and apoptosis of choline deficient ethionine supplemented diet-rat oval cells under the influence of 2-methoxyestradiol</article-title><source>J Physiol Pharmacol</source><volume>63</volume><fpage>669</fpage><lpage>676</lpage><year>2012</year><pub-id pub-id-type="pmid">23388483</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-5988"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F3;jcik</surname><given-names>M</given-names></name><name><surname>Wessely-Szponder</surname><given-names>J</given-names></name><name><surname>Kosior-Korzecka</surname><given-names>U</given-names></name></person-group><article-title>Proliferative and oxidative response of hepatocytes (Hep) and hepatic stellate cells (HSC) isolated from rats exposed to ketogenic diet</article-title><source>Pol J Vet Sci</source><volume>17</volume><fpage>703</fpage><lpage>711</lpage><year>2014</year><pub-id pub-id-type="doi">10.2478/pjvs-2014-0102</pub-id><pub-id pub-id-type="pmid">25638985</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-5988"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>CJ</given-names></name><name><surname>Cullen</surname><given-names>SP</given-names></name><name><surname>Clancy</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>RIPK1 can function as an inhibitor rather than an initiator of PIPK3-dependent necroptosis</article-title><source>FEBS J</source><volume>281</volume><fpage>4921</fpage><lpage>4934</lpage><year>2014</year><pub-id pub-id-type="doi">10.1111/febs.13034</pub-id><pub-id pub-id-type="pmid">25195660</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-5988"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upton</surname><given-names>JW</given-names></name><name><surname>Kaiser</surname><given-names>WJ</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus VIRA</article-title><source>Cell Host Microbe</source><volume>15</volume><fpage>290</fpage><lpage>297</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.chom.2012.01.016</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-5988"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christofferson</surname><given-names>DE</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Necroptosis as an alternative form of programmed cell death</article-title><source>Curr Opin Cell Biol</source><volume>22</volume><fpage>263</fpage><lpage>268</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.ceb.2009.12.003</pub-id><pub-id pub-id-type="pmid">20045303</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-5988"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Declercq</surname><given-names>W</given-names></name><name><surname>Vanden Berghe</surname><given-names>T</given-names></name><name><surname>Vandenabeele</surname><given-names>P</given-names></name></person-group><article-title>RIP kinase at the crossroads of cell death and survival</article-title><source>Cell</source><volume>138</volume><fpage>229</fpage><lpage>232</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.cell.2009.07.006</pub-id><pub-id pub-id-type="pmid">19632174</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-5988"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>K</given-names></name></person-group><article-title>RIPK1 and RIPK3: Critical regulators of inflammation and cell death</article-title><source>Trends Cell Biol</source><volume>25</volume><fpage>347</fpage><lpage>353</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.tcb.2015.01.001</pub-id><pub-id pub-id-type="pmid">25662614</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-5988"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Necroptosis in health and diseases</article-title><source>Semin Cell Dev Biol</source><volume>35</volume><fpage>14</fpage><lpage>23</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.07.013</pub-id><pub-id pub-id-type="pmid">25087983</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-5988" position="float">
<label>Figure 1.</label>
<caption><p>Representative macroscopic and microscopic features of the liver. (A) In PH rats treated with PBS, the liver appeared normal macroscopically, with visible lobule, (B) whereas the PH/DEN rats exhibited visible HCC (black arrows). (C) The PH rats exhibited normal hepatic parenchyma (D), whereas the PH/DEN rats exhibited a number of white macronodules (black arrows). The mean number of hepatocellular nodules in this group was 26&#x00B1;4 and their relative size was 1&#x2013;3 mm. Haematoxylin and eosin staining demonstrated the nodular appearance of HCC with frequent atypical (bizarre) cells and mitotic figures (black arrows). HCC, hepatocellular carcinoma; PH, partial hepatectomy; DEN, diethylnitrosamine.</p></caption>
<graphic xlink:href="etm-15-05-4448-g00.tiff"/>
</fig>
<fig id="f2-etm-0-0-5988" position="float">
<label>Figure 2.</label>
<caption><p>Protein expression of Afp, CK19 and Alb in PH and PH/DEN OCs. (A) Western blot analysis was performed to determine the protein expression of Afp, CK19 and Alb in PH and PH/DEN OCs. (B) Morphological phase-contrast characteristics of the isolated and cultured OCs. Immediately following isolation the OCs were small, with an oval-shaped nucleus and scant cytoplasm. Within the first week of incubation PH/DEN cells formed colonies and underwent clonal expansion with a high proliferative potential. Neither of the groups&#x0027; cells exhibited a hepatic myofibroblast-like appearance. In the PH group following 2 weeks in culture, cells with abundant cytoplasm and round nuclei typical of mature hepatocytes were present. The polygonal shape of the PH OCs was visible in the high magnification of the bracketed area (&#x00D7;400). Magnification, &#x00D7;200. PH, partial hepatectomy; DEN, diethylnitrosamine; OC, oval cell; Alb, albumin; CK19, cytokeratine-19; Afp, &#x03B1;-fetoprotein.</p></caption>
<graphic xlink:href="etm-15-05-4448-g01.tif"/>
</fig>
<fig id="f3-etm-0-0-5988" position="float">
<label>Figure 3.</label>
<caption><p>Protein expression of RIP1 and RIP3 in PH and PH/DEN OCs. Western blot analysis was performed to determine the protein expression of RIP1 and RIP3 in PH and PH/DEN OCs. The bands are representative of 3 separate experiments. &#x03B2;-actin (43 kDa) was used as a control of protein loading. PH, partial hepatectomy; DEN, diethylnitrosamine; RIP, receptor interacting protein; OC, oval cell.</p></caption>
<graphic xlink:href="etm-15-05-4448-g02.tif"/>
</fig>
<fig id="f4-etm-0-0-5988" position="float">
<label>Figure 4.</label>
<caption><p>Flow cytometry analysis of apoptotic OCs. Flow cytometry was used to determine the percentage of apoptotic OCs in the PH group and PH/DEN group (A). Representative scatters of the flow cytometry analysis in the PH and PH/DEN groups. Representative graphs of the flow cytometry analysis in the (B) PH and (C) PH/DEN groups. The data are presented as the means &#x00B1; standard deviation of 3 independent experiments. <sup>b</sup>P&#x003C;0.05 vs. PH/DEN at the same time point; <sup>c</sup>P&#x003C;0.05 vs. PH at 48 h. Representative images of 3 independent experiments are presented. PH, partial hepatectomy; DEN, diethylnitrosamine; OC, oval cell; PI, propidium iodide.</p></caption>
<graphic xlink:href="etm-15-05-4448-g03.tif"/>
</fig>
<fig id="f5-etm-0-0-5988" position="float">
<label>Figure 5.</label>
<caption><p>Proliferative activity of PH and PH/DEN OCs. BrdU incorporation into newly synthesized DNA of replicating cells was assessed using a monoclonal anti-BrdU antibody and a subsequent colorimetric detection. Data are presented as the mean &#x00B1; standard deviation. From 72 h of incubation, PH/DEN OCs exhibited significantly enhanced BrdU incorporation compared with PH OCs. &#x002A;P&#x003C;0.05 vs. the PH group at the same time point. PH, partial hepatectomy; DEN, diethylnitrosamine; OC, oval cell; BrdU, bromodeoxyuridine; OD, optical density.</p></caption>
<graphic xlink:href="etm-15-05-4448-g04.tif"/>
</fig>
<table-wrap id="tI-etm-0-0-5988" position="float">
<label>Table I.</label>
<caption><p>Body weight and serum levels of AST, ALT, AP and GGT in a PH/DEN rat model of hepatocarcinogensis.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Characteristic</th>
<th align="center" valign="bottom">PH rats</th>
<th align="center" valign="bottom">PH/DEN rats</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Initial weight (g)</td>
<td align="center" valign="top">215.00&#x00B1;5.37</td>
<td align="center" valign="top">209.00&#x00B1;7.20</td>
</tr>
<tr>
<td align="left" valign="top">Final weight (g)</td>
<td align="center" valign="top">300.00&#x00B1;6.63</td>
<td align="center" valign="top">266.00&#x00B1;10.80<sup><xref rid="tfn2-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">AST (U/l)</td>
<td align="center" valign="top">107.00&#x00B1;6.68</td>
<td align="center" valign="top">204.25&#x00B1;23.04<sup><xref rid="tfn2-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">ALT (U/l)</td>
<td align="center" valign="top">49.25&#x00B1;3.09</td>
<td align="center" valign="top">71.65&#x00B1;2.75<sup><xref rid="tfn2-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">AP (U/l)</td>
<td align="center" valign="top">73.25&#x00B1;4.34</td>
<td align="center" valign="top">137.75&#x00B1;9.10<sup><xref rid="tfn2-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">GGT (U/l)</td>
<td align="center" valign="top">&#x00A0;&#x00A0;5.47&#x00B1;0.25</td>
<td align="center" valign="top">&#x00A0;&#x00A0;59.25&#x00B1;9.57<sup><xref rid="tfn2-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-etm-0-0-5988"><p>Data are presented as the mean &#x00B1; standard deviation.</p></fn>
<fn id="tfn2-etm-0-0-5988"><label>a</label><p>P&#x003C;0.05 vs. PH rats. AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP, alkaline phosphatase; GGT, &#x03B3;-glutamyl transferase; PH, partial hepatectomy; DEN, diethylnitrosamine.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-etm-0-0-5988" position="float">
<label>Table II.</label>
<caption><p>Protein expression of RIP1 and RIP3.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th align="center" valign="bottom" colspan="2">PH</th>
<th align="center" valign="bottom" colspan="2">PH/DEN</th>
</tr>
<tr>
<th/>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
<th align="center" valign="bottom" colspan="2"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Protein</th>
<th align="center" valign="bottom">Time point</th>
<th align="center" valign="bottom">&#x0025; Adj.Vol.</th>
<th align="center" valign="bottom">Density (INT/mm<sup>2</sup>)</th>
<th align="center" valign="bottom">&#x0025; Adj.Vol.</th>
<th align="center" valign="bottom">Density (INT/mm<sup>2</sup>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">RIP1</td>
<td align="center" valign="top">48 h</td>
<td align="center" valign="top">12.47</td>
<td align="center" valign="top">2,924.40</td>
<td align="center" valign="top">6.84</td>
<td align="center" valign="top">2,437.00<sup><xref rid="tfn4-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td/>
<td align="center" valign="top">72 h</td>
<td align="center" valign="top">10.92</td>
<td align="center" valign="top">2,879.56</td>
<td align="center" valign="top">10.89</td>
<td align="center" valign="top">2,868.11</td>
</tr>
<tr>
<td/>
<td align="center" valign="top">1st week</td>
<td align="center" valign="top">10.98</td>
<td align="center" valign="top">2,884.67</td>
<td align="center" valign="top">16.20</td>
<td align="center" valign="top">3,246.00<sup><xref rid="tfn4-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td/>
<td align="center" valign="top">2nd week</td>
<td align="center" valign="top">12.49</td>
<td align="center" valign="top">2,938.56</td>
<td align="center" valign="top">17.89</td>
<td align="center" valign="top">3,488.89<sup><xref rid="tfn4-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">RIP3</td>
<td align="center" valign="top">48 h</td>
<td align="center" valign="top">14.57</td>
<td align="center" valign="top">3,163.56</td>
<td align="center" valign="top">12.43</td>
<td align="center" valign="top">2,914.89</td>
</tr>
<tr>
<td/>
<td align="center" valign="top">72 h</td>
<td align="center" valign="top">13.34</td>
<td align="center" valign="top">3,015.11</td>
<td align="center" valign="top">13.40</td>
<td align="center" valign="top">3,069.78</td>
</tr>
<tr>
<td/>
<td align="center" valign="top">1st week</td>
<td align="center" valign="top">9.95</td>
<td align="center" valign="top">2,833.11</td>
<td align="center" valign="top">16.28</td>
<td align="center" valign="top">3,360.89<sup><xref rid="tfn4-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td/>
<td align="center" valign="top">2nd week</td>
<td align="center" valign="top">9.20</td>
<td align="center" valign="top">2,812.56</td>
<td align="center" valign="top">18.20</td>
<td align="center" valign="top">3,547.67<sup><xref rid="tfn4-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-etm-0-0-5988"><p>The density of bands was expressed by the pixels in the volume divided by the area of the volume.</p></fn>
<fn id="tfn4-etm-0-0-5988"><label>a</label><p>P&#x003C;0.05 vs. PH rats. &#x0025; Adj.Vol., the volume expressed by the percentage of all the volumes in the image; PH, partial hepatectomy; DEN, diethylnitrosamine; RIP, receptor interacting protein; INT, intensity per mm<sup>2</sup>.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-etm-0-0-5988" position="float">
<label>Table III.</label>
<caption><p>Superoxide generation by OCs isolated from PH and DEN rats (nM/25&#x00D7;10<sup>4</sup>).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">24 h</th>
<th align="center" valign="bottom">48 h</th>
<th align="center" valign="bottom">72 h</th>
<th align="center" valign="bottom">1st week</th>
<th align="center" valign="bottom">2nd week</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">PH</td>
<td align="center" valign="top">0.70&#x00B1;0.03</td>
<td align="center" valign="top">1.10&#x00B1;0.2</td>
<td align="center" valign="top">2.20&#x00B1;0.43<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-0-0-5988" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">2.50&#x00B1;0.37<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-0-0-5988" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">2.00&#x00B1;0.31<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-0-0-5988" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">PH/DEN</td>
<td align="center" valign="top">1.67&#x00B1;0.36<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">1.89&#x00B1;0.5</td>
<td align="center" valign="top">3.20&#x00B1;0.58<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-0-0-5988" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">3.70&#x00B1;0.27<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-0-0-5988" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">3.20&#x00B1;0.37<sup><xref rid="tfn5-etm-0-0-5988" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-0-0-5988" ref-type="table-fn">b</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn5-etm-0-0-5988"><label>a</label><p>P&#x003C;0.05 vs. 24 h PH group.</p></fn>
<fn id="tfn6-etm-0-0-5988"><label>b</label><p>P&#x003C;0.05 vs. 24 h PH/DEN. PH, partial hepatectomy; DEN, diethylnitrosamine.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
